The acute effects of mirtazapine on pain related behavior in healthy animals

Neurosciences

Volumn 16, Issue 3, 2011, Pages 217-223

  Kilic, Fatma S ^a   Dogan, Ali E ^a   Baydemir, Canan ^a   Erol, Kevser ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

MIRTAZAPINE; NEURONAL NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HOT PLATE TEST; MALE; MOUSE; NONHUMAN; PAIN; RAT; SPRAGUE DAWLEY RAT; TAIL FLICK TEST; WRITHING TEST;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ARGININE; BEHAVIOR, ANIMAL; CYPROHEPTADINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HIPPOCAMPUS; MALE; MIANSERIN; MICE; NALOXONE; NARCOTIC ANTAGONISTS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE I; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN ANTAGONISTS;

EID: 79959359471     PISSN: 13196138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Lynch ME. Antidepressants as analgesics: a review of randomized controlled trials. J Psychiatry Neurosci 2001; 26: 30-36.
2. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999; 83: 389-400.
3. Davies J. A strategy for chronic pain. Practitioner 1997; 241: 452-458.
4. Spiegel K, Kalb R, Pasternak GW. Analgesic activity of tricyclic antidepressants. Ann Neurol 1983; 13: 462-465.
5. Milligan K. Prescribing antidepressants in general practice. Tricyclic antidepressants are also used for relief of chronic pain. BMJ 1997; 314: 827-828.
6. Bowsher D. Neurogenic pain syndromes and their management. Br Med Bull 1991; 47: 644-666.
7. Sindrup SH, Otto M, Finnerup NB, Jensen TS. Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol 2005; 96: 399-409.
8. Kalso E, Tasmuth T, Neuvonen PJ. Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer. Pain 1996; 64: 293-302.
9. Weber WE. [Pharmacotherapy for neuropathic pain caused by injury to the afferent nerve fibers]. Ned Tijdschr Geneeskd 2001; 145: 813-617. Dutch.
10. Krell HV, Leuchter AF, Cook IA, Abrams M. Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain. Psychosomatics 2005; 46: 379-384.
11. Arnold LM, Keck PE Jr, Welge JA. Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 2000; 41: 104-113.
12. Tomkins GE, Jackson JL, O'Malley PG, Balden E, Santoro JE. Treatment of chronic headache with antidepressants: a metaanalysis. Am J Med 2001; 111: 54-63.
13. Giannopoulos S, Kosmidou M, Sarmas I, Markoula S, Pelidou SH, Lagos G, et al. Patient compliance with SSRIs and gabapentin in painful diabetic neuropathy. Clin J Pain 2007; 23: 267-269.
14. Varia I, Logue E, O'Connor C, Newby K, Wagner HR, Davenport C, et al. Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin. Am Heart J 2000; 140: 367-372.
15. de Boer TH, Maura G, Raiteri M, de Vos CJ, Wieringa J, Pinder RM. Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers. Neuropharmacology 1988; 7: 399-408.
16. Pinder RM, Wieringa JH. Third-generation antidepressants. Med Res Rev 1993; 13: 259-325.
17. De Boer T, Nefkens F, Van Helvoirt A. The alpha 2-adrenoceptor antagonist Org 3770 enhances serotonin transmission in vivo. Eur J Pharmacol 1994; 253: R5-R6.
18. O'Connor WT, Leonard BE. Effect of chronic administration of the 6-aza analogue of mianserin (Org. 3770) and its enantiomers on behaviour and changes in noradrenaline metabolism of olfactory-bulbectomized rats in the "open field" apparatus. Neuropharmacology 1986; 25: 267-270.
19. Andrews JS, Jansen JHM, Linders S, Princen A, Drinkenburg WHIM, Coenders CJH, et al. Effect of imipramine or mirtazapine on operant performance in rats. Drug Dev Res 1994; 32: 58-66.
20. Haffner F. Experimentelle prufung schmerzstellender mittel. Deutsch Me Worchen-schr 1929; 55: 731-733.
21. D'Amour FE, Smith DL. A method for determining loss of pain sensation. J Pharmacol Exp Ther 1941; 72: 74-79.
22. Tjølsen A, Lund A, Berge OG, Hole K. An improved method for tail-flick testing with adjustment for tail skin temperature. J Neurosci Methods 1989; 26: 259-265.
23. Woolfe G, MacDonald AD. The evaluation of analgesic action of pethidine hydrochloride (Demerol). J Pharmacol Exp Ther 1994; 80: 300-307.
24. Eddy NB, Leimbach D. Synthetic analgesics. II. Diethienylbutenyl- and dithienylbuthylamines. J Pharmacol Exp Ther 1953; 107: 385-393.
25. Koster R, Anderson M, Bee EJ. Acetic acid for analgesic screening. Fed Proc 1959; 18: 412.
26. Kayaalp SO, editor. Medical Pharmacology in terms of Radional Therapy. Ankara (TR): Hacettepe Tas; 1998. p. 745-752.
27. Gray AM, Spencer PS, Sewell RD. The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds. Br J Pharmacol 1998; 124: 669-674.
28. Valverde O, Micó JA, Maldonado R, Mellado M, Gibert-Rahola J. Participation of opioid and monoaminergic mechanisms on the antinociceptive effect induced by tricyclic antidepressants in two behavioural pain tests in mice. Prog Neuropsychopharmacol Biol Psychiatry 1994; 18: 173-192.
29. Marchand F, Ardid D, Chapuy E, Alloui A, Jourdan D, Eschalier A. Evidence for an involvement of supraspinal deltaand spinal mu-opioid receptors in the antihyperalgesic effect of chronically administered clomipramine in mononeuropathic rats. J Pharmacol Exp Ther 2003; 307: 268-274.
30. Hamon M, Gozlan H, Bourgoin S, Benoliel JJ, Mauborgne A, Taquet H, et al. Opioid receptors and neuropeptides in the CNS in rats treated chronically with amoxapine or amitriptyline. Neuropharmacology 1987; 26: 531-539.
31. Reichenberg K, Gaillard-Plazza G, Montastruc JL. Influence of naloxone on the antinociceptive effects of some antidepressant drugs. Arch Int Pharmacodyn Ther 1985; 275: 78-85.
32. Schreiber S, Backer MM, Pick CG. The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms. Neurosci Lett 1999; 273: 85-88.
33. Bonnefont J, Chapuy E, Clottes E, Alloui A, Eschalier A. Spinal 5-HT1A receptors differentially influence nociceptive processing according to the nature of the noxious stimulus in rats: effect of WAY-100635 on the antinociceptive activities of paracetamol, venlafaxine and 5-HT. Pain 2005; 114: 482-490.
34. Zhang R, Nagata T, Hayashi T, Miyata M, Kawakami Y. Intracerebroventricular injection of trazodone produces 5-HT receptor subtype mediated anti-nociception at the supraspinal and spinal levels. Eur Neuropsychopharmacol 2004; 14: 419-424.
35. Yokogawa F, Kiuchi Y, Ishikawa Y, Otsuka N, Masuda Y, Oguchi K, et al. An investigation of monoamine receptors involved in antinociceptive effects of antidepressants. Anesth Analg 2002; 95: 163-168.
36. Siegmund E, Cadmus R, Lu G. A method for evaluating both non-narcotic and narcotic analgesics. Proc Soc Exp Biol Med 1957; 95: 729-731.